Vor Biopharma (VOR)
US Market

Vor Biopharma (VOR) Stock Price & Analysis


VOR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.05 - $7.57
Previous Close$2.1
Average Volume (3M)103.14K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$186.90M
Total Debt (Recent Filing)$37.51M
Price to Earnings (P/E)-1.0
Nov 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.02
Shares Outstanding67,538,680
10 Day Avg. Volume82,863
30 Day Avg. Volume103,138
Standard Deviation0.20
Financial Highlights & Ratios
Price to Book (P/B)0.70
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Price Target Upside642.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Vor Biopharma’s price range in the past 12 months?
Vor Biopharma lowest stock price was $2.05 and its highest was $7.57 in the past 12 months.
    What is Vor Biopharma’s market cap?
    Currently, no data Available
    When is Vor Biopharma’s upcoming earnings report date?
    Vor Biopharma’s upcoming earnings report date is Nov 09, 2023 which is in 41 days.
      How were Vor Biopharma’s earnings last quarter?
      Vor Biopharma released its earnings results on Aug 10, 2023. The company reported -$0.45 earnings per share for the quarter, missing the consensus estimate of -$0.421 by -$0.029.
        Is Vor Biopharma overvalued?
        According to Wall Street analysts Vor Biopharma’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Vor Biopharma pay dividends?
          Vor Biopharma does not currently pay dividends.
          What is Vor Biopharma’s EPS estimate?
          Vor Biopharma’s EPS estimate is -$0.47.
            How many shares outstanding does Vor Biopharma have?
            Vor Biopharma has 67,538,680 shares outstanding.
              What happened to Vor Biopharma’s price movement after its last earnings report?
              Vor Biopharma reported an EPS of -$0.45 in its last earnings report, missing expectations of -$0.421. Following the earnings report the stock price went up 14.397%.
                Which hedge fund is a major shareholder of Vor Biopharma?
                Among the largest hedge funds holding Vor Biopharma’s share is RA Capital Management. It holds Vor Biopharma’s shares valued at 70M.


                  Vor Biopharma Stock Smart Score

                  The Vor Biopharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Vor Biopharma

                  Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies.


                  Top 5 ETFs holding VOR

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold VOR. The ETFs are listed according to market value of VOR within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Kura Oncology
                  Voyager Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis